Estimated U.S. Annual Cost of Initial Cancer Screening $43 Billion in 2021
By Elana Gotkine HealthDay Reporter
MONDAY, Aug. 5, 2024 -- In 2021, the estimated total health care costs for initial cancer screening were $43 billion in the United States, according to a study published online Aug. 6 in the Annals of Internal Medicine.
Michael T. Halpern, M.D., Ph.D., from the National Cancer Institute in Bethesda, Maryland, and colleagues estimated the annual cost of initial cancer screening in the United States in 2021 using national health care survey and cost resources data.
The researchers found that in 2021, total health care costs for initial cancer screenings were estimated at $43 billion in the United States. Of the costs, about 88.3, 8.5, and 3.2 percent were attributed to private insurance; Medicare; and Medicaid, other government programs, and uninsured persons, respectively. Colorectal cancer screening represented about 64 percent of the total cost; screening colonoscopy represented more than half of the total (55 percent). Major drivers of the total estimated costs of screening were facility costs (amounts paid to the facilities where testing occurred).
"This study provides previously unavailable estimates for the annual medical care cost of cancer screening in the United States," the authors write. "Identification of these costs and the drivers for cancer screening costs are critical to help inform policy and develop programmatic priorities, particularly for enhancing access to recommended cancer screening services."
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted August 2024
Read this next
Casual Blood Glucose Testing Misses ~70 Percent of Gestational Diabetes Cases
FRIDAY, Sept. 27, 2024 -- Casual blood glucose (CBG) testing at 24 to 28 gestational weeks misses about 70 percent of women with gestational diabetes mellitus (GDM), according to...
Large Difference in Survival Seen for Preemies Born at 25 Versus 22 Weeks
FRIDAY, Sept. 27, 2024 -- For infants born prematurely, survival increases considerably for those born at 25 versus 22 gestational weeks, according to a study published online...
Adverse Brain Health Outcomes Increased for Sexual, Gender Minority Groups
FRIDAY, Sept. 27, 2024 -- Sexual and gender-minority (SGM) persons have increased odds of adverse brain health outcomes, according to a study published online Sept. 25 in...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.